Oncology Regulatory Expertise and Early Guidance (OREEG)
Project Catalyst’s Oncology Regulatory Expertise and Early Guidance (OREEG), is an educational initiative of the Oncology Center of Excellence (OCE),
Related Articles
Interactive Maps
Tip: Hover on a state to see its rate (and 95% C.I.). Click a state to show its counties.
Anemia During Ruxolitinib Treatment Is Associated With Worse Outcomes for Patients With MF | Blood Cancers Today
In the real-world setting, patients with MF and anemia who were treated with ruxolitinib had poorer survival outcomes than patients without anemia.
OCE Conversations on Cancer – Cervical Cancer Treatment Innovation: A Collaborative Discussion
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Upcoming FDA-AACR Workshop Will Discuss DPD Deficiency Testing
A FDA-AACR workshop will discuss the considerations for DPD deficiency testing before chemotherapy with fluoropyrimidines.
Oncology Center of Excellence Guidance Documents
Recently added guidance documents regarding oncology and malignant hematology
Spotlight on Seasonal Depression: Why Indoor Tanning Isn’t an Effective Treatment
Seasonal Affective Disorder (SAD) affects millions of Americans, but hopping into a tanning bed won’t help. Visible light therapy is safer.
Social determinants of health and US cancer screening interventions: A systematic review
There remains a need to synthesize linkages between social determinants of health (SDOH) and cancer screening to reduce persistent inequities contributing to the US cancer…
Home | Multiple Myeloma Hub
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
It can be a lifesaving tool, especially during an emergency
Keeping track of when, how and why you use medications is important for your health and safety. The list can be a lifesaver, especially during…
OCE ENGAGE: A Project Community Newsletter
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers